Skip to main content

Paul Mattheis

Analyst

Stifel

Equibles does not estimate personal net worth.

About Paul Mattheis

Paul Mattheis is recorded as Analyst at Stifel. Paul Mattheis has spoken on 1 earnings call across 1 company, most recently for Rhythm Pharmaceuticals, Inc. on August 4, 2026. The companies whose calls Paul Mattheis spoke on are classified in the Healthcare sector.

Paul Mattheis on recent calls

“And I was wondering if you could comment on what you're seeing as it relates to either concomitant use with GLP-1s or whether there's physicians or many physicians are kind of looking to try a GLP-1 before in Sivri.”
Analyst — Stifel, Rhythm Pharmaceuticals Q2 2026 Earnings Conference Call ·

Affiliation history

  • Stifel

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity